ARCHIVES

Drug Shortages Prompt Doctors, Societies to Consider Non-Profit Pharma Company

This article is from The Cancer Letter archive.

Vol. 37 No. 33 | September 9, 2011

Download PDF Visit The Full Archive

Related Articles

PDQ Evaluation to Cost NCI More Than Reported

June 29, 1990

SWOG Restarts Gynecologic Malignancies Committee.

May 16, 2008

Taking on question of cost and outcomes, CMS turns to expert in cancer care quality.

June 3, 2005

Two Studies Advance The Treatment Of Early-Stage And Later Breast Cancer

June 27, 2008

NCI’s Drug Screen Tests 400 Agents A Week; Recompetition Of Contracts Approved

February 26, 1993

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

April 29, 2011